Superbugs: An Arms Race against Bacteria

Unnecessary use of antibiotics in both humans and animals accelerates the evolution of drug-resistant bacteria, with potentially catastrophic consequences. Our best defenses against infectious disease could cease to work, surgical procedures would become deadly, and we might again find small cuts to be life-threatening. The problem of drug resistance already kills over one million people across the world every year and has huge economic costs. Without action, this problem will become significantly worse. [read more]

Superbugs: An Arms Race against Bacteria2022-09-22T15:39:01+00:00

High Levels Of Antibiotic Resistance Found Worldwide

WHO's new Global Antimicrobial Surveillance System reveals widespread occurrence of antibiotic resistance among 500,000 people with suspected bacterial infections across 22 countries. The most commonly reported resistant bacteria were Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pneumoniae, followed by Salmonella spp. Among patients with suspected bloodstream infection, the proportion that had bacteria resistant to at least one of the most commonly used antibiotics ranged tremendously between different countries – from zero to 82%. [read more]

High Levels Of Antibiotic Resistance Found Worldwide2022-09-22T17:04:20+00:00

Critical Assessment of Incentive Strategies for Development of Novel Antibiotics

Concern has emerged in the public health arena regarding the deadly combination of increasing antimicrobial resistance and stunted antibiotic development. Antimicrobial resistance is an evolutionary adaptation that will not cease, but can be mitigated with careful stewardship of existing antibiotics. The decline in investment in antibiotic development is a complex, multifactorial market failure arising from the nature of antibiotic prescribing, current pricing, existing patent structures, and societal expectations. [read more]

Critical Assessment of Incentive Strategies for Development of Novel Antibiotics2022-09-22T17:06:09+00:00
Go to Top